Drugs Made In America Acquisition Corp. Ordinary Shares

Drugs Made In America Acquisition Corp. Ordinary Shares

DMAA - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$219.04M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Drugs Made In America Acquisition Corp. Ordinary SharesDrugs Made In America Acquisition Corp. Ordinary Shares55.6-4%--

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$219.04 Million
Enterprise Value$219.97 Million
Earnings per Share$0.19
Beta0
Outstanding Shares20,095,314

Return

Return on Equity4.42%ROE
Return on Assets4.15%
Return on Invested Capital-1.83%

Valuation & Multiples

P/E Ratio55.55P/E Ratio
PEG-226.35PEG
Price to Sales-Price to Sales
Price to Book Ratio1.82Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-83.53
Enterprise Value to Net Income36
Total Debt to Enterprise0
Debt to Equity0.01Debt to Equity

Revenue Sources

No data

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %36.15%▼ 23.38%
Total Invested$71.71M▼ 42.58%
Investors Holding11▼ 12.00%

About Drugs Made In America Acquisition Corp. Ordinary Shares

2 employees
CEO: Roger Bendelac

Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with...